<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>Gout Attack Management and Follow-up</title>
  <style>
    body { font-family: Arial, sans-serif; line-height: 1.6; margin: 20px; color: #333; }
    h1, h2, h3 { color: #0056a6; }
    ul { margin-left: 20px; }
    .source { font-size: 0.9em; color: #555; }
  </style>
</head>
<body>

  <h1>Acute Gout Attack: Management and Follow-up (Family Medicine)</h1>

  <h2>Initial Evaluation</h2>
  <ul>
    <li>Rule out septic arthritis and other acute monoarthritis causes.</li>
    <li>Assess the need for joint aspiration or imaging if the diagnosis is uncertain.</li>
    <li>Provide adequate pain control and rest; apply ice locally.</li>
  </ul>

  <h2>Acute Management</h2>
  <ul>
    <li><strong>Nonpharmacologic:</strong> Rest the affected joint; apply ice packs.</li>
    <li><strong>Pharmacologic therapy (start within 24 hours):</strong>
      <ul>
        <li><strong>First-line options:</strong> NSAIDs, colchicine, or glucocorticoids.</li>
        <li><strong>Combination therapy:</strong> Consider if ≥4 joints or severe pain.</li>
        <li><strong>Continue existing urate-lowering therapy</strong> if the patient is already on it.</li>
      </ul>
    </li>
  </ul>

  <h3>Drug Details</h3>
  <ul>
    <li><strong>NSAIDs:</strong> Naproxen, indomethacin, or ibuprofen for 3–5 days (shortest effective duration). Avoid in renal/hepatic impairment or peptic ulcer disease.</li>
    <li><strong>Colchicine:</strong> Best if started within 12 hours of onset. Reduce dose in CKD or hepatic impairment. Common side effects: diarrhea, nausea.</li>
    <li><strong>Glucocorticoids:</strong> Prednisone or prednisolone for 5 days or tapered regimen; intra-articular injections if 1–2 accessible joints.</li>
  </ul>

  <h2>Follow-up and Long-Term Management</h2>
  <ul>
    <li>Reassess within 1–2 weeks to confirm resolution of symptoms.</li>
    <li>Consider starting <strong>urate-lowering therapy (ULT)</strong> if:
      <ul>
        <li>≥2 flares per year</li>
        <li>Tophi present</li>
        <li>CKD stage ≥2</li>
        <li>Uric acid nephrolithiasis</li>
      </ul>
    </li>
    <li><strong>Lifestyle and comorbidity management:</strong>
      <ul>
        <li>Limit alcohol, red meat, shellfish, and high-fructose corn syrup.</li>
        <li>Encourage weight loss if overweight.</li>
        <li>Screen and manage sleep apnea, hypertension, and diabetes.</li>
        <li>Use losartan preferentially; avoid hydrochlorothiazide.</li>
      </ul>
    </li>
  </ul>

  <h2>Family Medicine Follow-up Plan</h2>
  <ul>
    <li>Review serum uric acid levels 2–4 weeks after initiating or adjusting ULT.</li>
    <li>Monitor renal and hepatic function if on long-term therapy.</li>
    <li>Provide education on early recognition and self-management of flares.</li>
    <li>Coordinate care with rheumatology for recurrent or refractory cases.</li>
  </ul>

  <p class="source">
    Source: <a href="https://www.amboss.com/us/knowledge/gout-and-hyperuricemia?utm_medium=chatgpt-plugin&utm_source=chatgpt" target="_blank">
      AMBOSS – Gout and Hyperuricemia
    </a>
  </p>

</body>
</html>
